Verenafusp alfa

N/A

Report date: 2024/06/27 17:34:28
NME

Base Information

Drug NameVerenafusp alfa
Drug Alias NameGNR-055
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIduronate-2-sulfatase modulators
TargetsIduronate-2-sulfatase
Therapy Area/IndicationsMetabolic DiseasesMucopolysaccharidosis II
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryRussian Federation
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesGenerium Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesGenerium Pharmaceuticals
Inactive CompaniesN/A
Active IndicationsMetabolic DiseasesMucopolysaccharidosis II
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A